Skip to content
Peptigraph home

Peptides for Depression

The peptides people most often research for depression, with how much evidence exists for each. A long list does not mean any of them is proven to work in people.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureUpdated
Peptides listed
3
With human trials
1
FDA approved (any use)
1
Showing 3 peptides · ordered by search interest for this goal
  1. SelankTuftsin analogAnimal evidence, 2 of 4Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova 2008, PMID 18661785Human2Animal5Summarised1Not FDA approved · research chemicalFor depressionOverview
  2. SemaxACTH(4-10) analogAnimal evidence, 2 of 4European journal of pharmacology 2024, PMID 39442746Human0Animal6Summarised1PCAC voted 8–5 for 503A (Jul 2026)For depressionOverview
  3. TirzepatideGLP-1 / GIP dual agonistHuman RCT evidence, 4 of 4Obesity 2026, PMID 41537305Human35Animal2Summarised1FDA approved (Mounjaro, Zepbound)For depressionOverview
Read this first

What this list does not show

Search demand tells you what people are curious about, not what works. Read each peptide's evidence before anything else.

Search interest is not evidence

This list follows what people search for and discuss. It says nothing about how well any peptide works.

Animal results may not carry over

Doses, routes and effects seen in rodents or cell dishes often have no tested human equivalent.

Approval covers specific uses

An FDA approval applies to the conditions and doses on the label, not to every goal a drug is searched with.

Combinations are a separate question

Blends and stacks put several peptides together. Evidence for one peptide is not evidence for the mix.

What depression is

MedlinePlus describes depression as a serious mood disorder, far more than a few days of feeling sad or irritable, that can make basic activities like sleeping, eating or working difficult.[4]

It adds that depression often needs long-term treatment and that getting help at the first sign of a problem can help manage symptoms.[4]

Rodent data for the research peptides, safety analyses for tirzepatide

Selank has 2 human-only and 5 animal papers on depression and Semax has 6 animal papers and none in people, while tirzepatide has 35 human-only papers mostly from obesity trials.

Calculated from source our PubMed count ledger ledger (PubMed title/abstract counts, 2026-10-02); selank human only 2, animal only 5, rct 0; semax human only 0, animal only 6, rct 0; tirzepatide human only 35, animal only 2, rct 1. Formula: Counts copied from each peptide ledger: humanOnly = human studies not also tagged animal, animalOnly = animal studies not tagged human, rct = human randomised trials. They count papers mentioning the topic, not positive results.

In WAG/Rij rats, repeated injection of high-dose Selank counteracted depression-like behaviour (increased immobilization in the forced swimming test and decreased sucrose intake).[1]

In BALB/c mice, a single low dose of Selank reduced immobility in the forced swimming test, but it had no significant effect after repeated injection or at higher doses.[1]

In rats, chronic Semax treatment reversed or substantially attenuated chronic-stress-induced anhedonia and a decrease in hippocampal BDNF.[2]

In a safety analysis of tirzepatide trials, tirzepatide-treated participants were less likely to shift to a more severe PHQ-9 category (18.2% vs. 24.3%).[3]

In the same analysis, 0.6% of participants in each group reported suicidal ideation on the C-SSRS, most of it considered low risk.[3]

A different study reported that patients on GLP-1 receptor agonists had a 195% higher risk of major depression, 108% for anxiety and 106% for suicidal behavior.[5]

Common questions

What are the best peptides for depression?

None is shown to treat depression in people; the research peptides Selank and Semax have rodent data only.[2]

Are there peptides for mood?

Semax reversed anhedonia in stressed rats, an animal-only finding with no human mood trial in the files.[2]

What is the best peptide for depression?

No comparison exists; the best-documented human mood data are safety analyses of tirzepatide, not depression trials.[3]

Do GLP-1 drugs affect depression risk?

Evidence conflicts: a trial-based analysis found less worsening of PHQ-9 category on tirzepatide, while another study reported a higher depression risk with GLP-1 drugs.[5]

Sources

  1. 1[Effects of heptapeptide selank on genetically-based and situation-provoked symptoms of depression in behavior in WAG/Rij and Wistar rats, and in BALB/c mice].Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova · 2008PMID 18661785Accessed 2 Oct 2026
  2. 2Antidepressant-like and antistress effects of the ACTH(4-10) synthetic analogs Semax and Melanotan II on male rats in a model of chronic unpredictable stress.European journal of pharmacology · 2024PMID 39442746Accessed 2 Oct 2026
  3. 3Psychiatric Safety of Tirzepatide in People With Obesity and No Known Major Psychopathology: A Post Hoc Analysis of SURMOUNT.Obesity (Silver Spring, Md.) · 2026PMID 41537305Accessed 2 Oct 2026
  4. 4Official web pageOfficial web page · web page
  5. 5The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy.Scientific reports · 2024PMID 39424950Accessed 2 Oct 2026

Found an error? Report a correction.